RPDC (TAQNIA) | December 2018
SaudiVax and RPDC (TAQNIA) signed on development of monoclonal antibody for infectious agents from patent to product.
Cytiva| December 2018
SaudiVax and GE (Cytiva) signed a contract for manufacturing and installation of bioprocessing equipment in Saudi Arabia
Voirx| Jan 2019
A strategic partnership was signed between SaudiVax and Voirx to develop and localize cellular and gene therapies in KSA
Pangen| April 2019
SaudiVax and Pangen signed an agreement to localize, sell, distribute, and produce 3 biosimilars in Saudi Arabia
NIBRT| Sep 2019
SaudiVax and NIBRT signed a contract for a specialized training program
FDB | December 2019
SaudiVax and FDB signed the first contract development and manufacturing project for a novel monoclonal antibody.
KAU | March 2020
SaudiVax and King Abdulaziz University signed vaccine and biotechnology research and development localization.
J&J | March 2020
SaudiVax and Johnson & Johnson signed MOU for technology transfer for biologics manufacturing.
Merck| March 2020
SaudiVax, Merck signed contract for biomanufacturing localization project in the Kingdom
MERCK (MSD) | April 2020
SaudiVax and MERCK (MSD) signed a collaborative research agreement for early drug discovery and exploratory research on corona viruses
SONA Nanotech | June 2020
SaudiVax and SONA Nanotech signed a contract research agreement and a manufacturing agreement for a rapid COVID-19 diagnostic
FDB | Sep 2020
After development with FDB, SaudiVax received filled vials of the formulated novel monoclonal antibody (Demo Material Run).
MERCK| December 2020
SaudiVax and MERCK signed with Industrial Clusters a feasibility study on localizing advanced biologics manufacturing